Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anant Vatsayan
Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Stomatocytosis and Spherocytosis in a Patient With Novel Heterozygous Novel Mutation in the Erythrocyte Protein 4.2 Gene and Parenteral Nutrition-Associated Liver Disease
Clinical Research and Trials
Related publications
Evaluation of High-Dose Melphalan Toxicity by Age in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Toxicity Analysis of Propylene Glycol-Free Melphalan (Evomela®) Compared to Propylene Glycol-Based Melphalan Hydrochloride in Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Dose-Intense BCNU/Melphalan Regimen Followed by Autologous Hematopoietic Cell Transplantation (AHCT) Results in Prolonged PFS in Myeloma Patients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
High-Dose Therapy and Autologous Stem Cell Transplant in Older Adults With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Lymphocyte Subset Recovery and Outcome After Autologous Hematopoietic Stem Cell Transplantation for Plasma Cell Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Acute Cognitive Impairment in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplant
Cancer
Cancer Research
Oncology
MBL2 Polymorphism and Risk of Severe Infections in Multiple Myeloma Patients Receiving High-Dose Melphalan and Autologous Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Aggressive Neoplastic Plasma Cell Growth With MLL Gene Rearrangement After High-Dose Therapy With Autologous Stem Cell Support for Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
